1-6 of 6
Stephane Courby, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Franck E Nicolini, MD PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnès Guerci-Bresler, MD PhD, Aude Charbonnier, MD PhD, Martine Escoffre-Barbe, MD, Viviane Dubruille, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MD PhD, Valerie Coiteux, MD, Pascale Cony-Makhoul, MD, Pascal Lenain, MD, Lydia Roy, MD, Philippe Rousselot, MD PhD, Denis Guyotat, MD PhD, Jean-Christophe Ianotto, MD PhD, Martine Gardembas, MD, Eric Deconinck, MD PhD, Fabrice Larosa, MD, Denis Caillot, MD, Pascal Turlure, MD, Stephane Courby, MD, Philippe Quittet, MD, Eric Hermet, MD, Shanti Ame, MD, Simona Lapusan, MD, Alexandre Deloire, CRA, Stephane Morisset, BioStat, Madeleine Etienne, CRA, Delphine Rea, MD, Stephanie Dulucq, PharmD, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 494.
https://doi.org/10.1182/blood-2019-123674
Published: 2019
Journal Articles

First-Line Second Generation Tyrosine Kinase Inhibitors in Newly Diagnosed Accelerated Phase Chronic Myeloid Leukemia Patients.

Marie Balsat, MD, Vincent Alcazer, MD, Gabriel Etienne, MD PhD, Gaelle Fossard, MD, Francoise Huguet, MD, Marc G. Berger, MD PhD, Emilie Cayssials, MD, Aude Charbonnier, MD, Martine Escoffre-Barbe, MD, Hyacinthe Johnson-Ansah, MD, Viviane Dubruille, MD, Laurence Legros, MD PhD, Lydia Roy, MD, Alain Jacques Delmer, MD, Jean-Christophe Ianotto, MD PhD, Martine Gardembas, MD, Fabrice Larosa, Stephane Courby, MD, Shanti Ame, MD, Stephane Morisset, Stat, Francois-Xavier Mahon, MD PhD, Delphine Rea, MD, Franck Emmanuel Nicolini, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 48.
https://doi.org/10.1182/blood-2018-99-113058
Published: 2018
Journal Articles

Nilotinib Versus Nilotinib Combined to Pegylated-Interferon Alfa 2a in First-Line Chronic Phase Chronic Myelogenous Leukemia Patients. Interim Analysis of a Phase III Trial

Franck Emmanuel Nicolini, MD PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnes Guerci-Bresler, Aude Charbonnier, MD, Martine Escoffre-Barbe, MD, Viviane Dubruille, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MDPhD, Valerie Coiteux, MD, Pascale Cony-Makhoul, MD PhD, Pascal Lenain, MD, Lydia Roy, MD, Philippe Rousselot, Denis Guyotat, Jean-Christophe Ianotto, MD, Martine Gardembas, MD, Fabrice Larosa, MD, Denis Caillot, MD, Pascal Turlure, MD, Stephane Courby, MD, Philippe Quittet, MD, Eric Hermet, MD, Shanti Ame, MD, Simona Lapusan, MD, Verane Schwiertz, PharmD, Stephane Morisset, Stat, Madeleine Etienne, CRA, Delphine Rea, MD PhD, Stephanie Dulucq, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 899.
https://doi.org/10.1182/blood.V130.Suppl_1.899.899
Published: 2017
Journal Articles

Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) Registry

Brigitte Dupriez, MD, Sylvie Chevret, MD PhD, Jean-Christophe Ianotto, MD, Francoise Boyer, MD, Pascale Cony-Makhoul, MD, Gabriel Etienne, MD PhD, Mathieu Wemeau, MD, Jérome Rey, Laurent Knoops, MD PhD, Jean-Loup Demory, MD, Eric Lippert, PhD, Francois Girodon, MD PhD, Laurence Legros, MDPhD, Anne Vekhoff, MD, Stephane Courby, MD, Fabienne Vacheret, MD, Nathalie Cambier, MD, Stephane Giraudier, MD PhD, Suzanne Tavitian, MD, Kamel Laribi, Sandra Malak, Dana Ranta, MD, Fiorenza Barraco, MD, Isabelle Plantier, MD, Sophie Dupire, Marc Simon, MD, Selim Corm, MD, Ahmad AL Jijakli, MD, Philippe Rodon, MD, Lise Willems, MD PhD, Bohrane Slama, MD, Ronan Le Calloch, MD, Pierre Morel, MD, Valerie Ugo, MD PhD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3128.
https://doi.org/10.1182/blood.V128.22.3128.3128
Published: 2016
Journal Articles

Combination of Dasatinib and Peg-Interferon Alpha 2b in Chronic Phase Chronic Myeloid Leukemia (CP-CML) First Line: Preliminary Results of a Phase II Trial, from the French Intergroup of CML (Fi-LMC)

Lydia ROY, MD, Jean-Claude Chomel, PharmD PhD, Joelle Guilhot, PhD, Agnes Guerci-Bresler, MD, Martine Escoffre-Barbe, Stéphane Giraudier, MD PhD, Aude Charbonnier, Viviane Dubruille, MD, Françoise Huguet, Hyacinthe Johnson-Ansah, MD, Pascal Lenain, MD, Shanti Amé, MD, Gabriel Etienne, MD PhD, Franck E. Nicolini, Delphine Rea, MD PhD, Pascale Cony-Makhoul, MD, Stephane Courby, MD, Jean-Christophe Ianotto, MD, Laurence Legros, MD, Martine Delain, MD, Valérie Coiteux, MD, Eric Hermet, MD, Martine Gardembas, MD, Mathieu Molimard, MD PhD, Jean-Michel Cayuela, Marie Thibaud, CRA, Sophie Duranton, PharmD, Francois-Xavier Mahon, MD PhD, Philippe Rousselot, MD PhD Professor, Francois Guilhot, MD
Journal: Blood
Blood (2015) 126 (23): 134.
https://doi.org/10.1182/blood.V126.23.134.134
Published: 2015
Journal Articles

Long Term Results of a Multicenter Prospective Trial By the Lysa Group Evaluating the RiPAD+C Regimen (Combination of Rituximab, Bortezomib, Doxorubicin, Dexamethasone and Chlorambucil) As First-Line Therapy for Elderly Mantle Cell Lymphoma Patients (MCL): Prognostic Value of FDG-PET/CT

Julien Dubreuil, Roch Houot, MD PhD, Steven Le Gouill, Christiane Mounier, MD, Stéphane Courby, MD, Caroline Dartigeas, MD, Krimo Bouabdallah, MD, Marie Pierre Moles, MD, Alexis Magda, Olivier Tournilhac, MD, Mario Ojeda Uribe, Jean Cyril Bourre, Caroline Bodet-Milin, MD, Jean-Philippe Vuillez, MD PhD, Remy Gressin, MD
Journal: Blood
Blood (2014) 124 (21): 3070.
https://doi.org/10.1182/blood.V124.21.3070.3070
Published: 2014